Etoposide

ABL proto-oncogene 1, non-receptor tyrosine kinase ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24569990 Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage. 2014 Apr 11 1
2 24260231 Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis. 2013 2
3 22705319 BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response. 2012 Dec 21 3
4 19020542 BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold. 2009 Feb 1
5 19237191 The anti-apoptotic role of the unfolded protein response in Bcr-Abl-positive leukemia cells. 2009 Jul 1
6 15388581 Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells. 2005 Feb 1 1
7 15978941 Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference. 2005 Aug 2
8 15050919 BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint. 2004 Mar 1
9 11937320 The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells. 2002 Apr 1
10 12513785 [Cytokine-induced killer cells induce apoptosis of K562 cells expressed bcr-abl]. 2002 Jun 1
11 11123359 Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl. 2001 Jan 1
12 11237055 Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells. 2001 Mar 2
13 9516141 BCR-ABL delays apoptosis upstream of procaspase-3 activation. 1998 Apr 1 6